In cellular assays 29 inhibits the expression of c-MYC, the growth of lymphoma, myeloma, and AML cell lines, and sensitizes cells to the growth inhibition, DNA damage, and apoptosis induced by olaparib. The gene discussed is MYC; the disease is plasma cell myeloma.